Δ9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors
Δ9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors
复制标题
DOI:
10.1016/s0014-2999(99)00165-x
复制
发表时间:
1999-04-29
影响因子:
5
通讯作者:
Hornby, PJ
中科院分区:
文献类型:
--
作者:
Krowicki, ZK;Moerschbaecher, JM;Hornby, PJ
We investigated involvement of the autonomic nervous system in gastric motor and cardiovascular responses to ag-tetrahydrocannabinol (Delta(9)-THC) in anesthetized rats. Intravenously administered Delta(9)-THC evoked long-lasting decreases in intragastric pressure and pyloric contractility, bradycardia, and hypotension. The changes in gastric motor function and bradycardia were abolished by vagotomy and ganglionic blockade, whereas spinal cord transection prevented the hypotensive response. Administered intravenously alone, N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide, a putative cannabinoid CB1 receptor antagonist, evoked transient decrease in intragastric pressure, and hypertension that was associated with bradycardia. However, this agent completely blocked the gastric motor and cardiovascular responses to intravenous Delta(9)-THC. Application of Delta(9)-THC to the dorsal surface of the medulla resulted in small and short-lasting decreases in gastric motor and cardiovascular function. We conclude that the decrease in gastric motor function and bradycardia are partially due to an action of Delta(9)-THC in the dorsal medulla and that intact vagal nerves are required. The hypotension was mediated through sympathetic pathways. Both gastric motor and cardiovascular effects of peripherally administered Delta(9)-THC seem to be mediated through cannabinoid CB1 receptors. (C) 1999 Elsevier Science B.V. All rights reserved.